Results from Phase 2 clinical studies, CHAPTER-1 and RAPIDe-1, provide evidence of viability of bradykinin B2 receptor antagonism in management ...

KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced that five abstracts, including one late-breaking submission, ...

Data include a concurrent assessment of results collected from PGI and AMRA instruments, insights into clinically meaningful changes in HAE attack symptoms, and support for hierarchical ranking of ...

Kalbitor (ecallantide) is a medicine used to treat sudden attacks of hereditary angioedema (HAE). During an HAE attack, swelling happens in different areas of the body, such as your face, hands, feet, ...

(BPT) - In the U.S., about 7,000 people live with hereditary angioedema, or HAE, 1,2 a rare condition that results in unpredictable swelling attacks. 3-8 Symptoms often appear early in life and can ...

The FDA awards Fast Track designation to BW-20805 for hereditary angioedema, a therapy designed to reduce attacks through PKK ...

Learn to manage stress-induced angioedema with techniques like meditation and exercise, as well as a treatment plan from your doctor.